Oragenics Faces Delisting Concerns
Ticker: OGEN · Form: 8-K · Filed: Aug 16, 2024 · CIK: 1174940
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Oragenics might get delisted - big trouble ahead.
AI Summary
Oragenics, Inc. filed an 8-K on August 16, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates potential issues with meeting the listing requirements for its securities. The report also includes other events and financial statements/exhibits.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the company's stock being removed from its current exchange, impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards indicates significant financial or operational challenges that could lead to the stock being removed from an exchange.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- 1990 Main Street Suite 750 Sarasota , FL 34236 (address) — Principal executive offices
- 813 - 286-7900 (phone_number) — Registrant's telephone number
FAQ
What specific listing rule or standard has Oragenics, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Oragenics, Inc. has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is August 13, 2024.
What is Oragenics, Inc.'s IRS Employer Identification Number?
Oragenics, Inc.'s IRS Employer Identification Number is 59-3410522.
In which state was Oragenics, Inc. incorporated?
Oragenics, Inc. was incorporated in Florida (FL).
What is the Commission File Number for Oragenics, Inc.?
The Commission File Number for Oragenics, Inc. is 001-32188.
Filing Stats: 583 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-08-16 16:30:15
Key Financial Figures
- $2,000,000 — es stockholders' equity of no less than $2,000,000 if the Company has sustained losses fro
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex99-1.htm (EX-99.1) — 25KB
- 0001493152-24-032831.txt ( ) — 245KB
- ogen-20240813.xsd (EX-101.SCH) — 3KB
- ogen-20240813_lab.xml (EX-101.LAB) — 33KB
- ogen-20240813_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 16 thh day of August, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer